Your VATIVIO treatment will be prescribed by a doctor with experience in the use of anticancer therapies. Follow all the doctor’s instructions carefully. They may differ from the general information contained in this leaflet.
Do not take VATIVIO:
- if you know that you are hypersensitive (allergic) to the active substance or any of the other ingredients of VATIVIO.
- if you are pregnant or intend to become pregnant
- do not breastfeed your baby if you are taking VATIVIO. If this applies to you, tell your doctor without taking VATIVIO.
If you think you may be allergic, ask your doctor for advice.
Warnings and precautions:
Before taking VATIVIO, tell your doctor:
- if you have a liver, kidney or heart problem, or have had one of those problems.
- if you are receiving treatment with levothyroxine because your thyroid has been removed.
- if you are receiving treatment with other medicines, in particular medicines listed below in section “Other medicines and VATIVIO”.
- if you have ever had or might now have a hepatitis B infection. This is because during treatment with VATIVIO, hepatitis B may become active again. Your doctor will check for signs of this infection before treatment with VATIVIO is started.
Check with your doctor if you think any of these may apply to you. You may become more sensitive to the sun while taking VATIVIO. It is important to cover sun-exposed areas of skin and use sunscreen with high sun protection factor (SPF). These precautions are also applicable to children.
During treatment with VATIVIO, tell your doctor straight away if you put on weight very quickly. VATIVIO may cause your body to retain water (severe fluid retention).
While you are taking VATIVIO, your doctor will regularly check whether the medicine is working. You will also have blood tests and be weighed regularly.
VATIVIO and older people:
VATIVIO can be used by patients over the age of 65.
Children and adolescents
VATIVIO is a treatment for children and adolescents with CML. There is no experience with the use of VATIVIO in children below 2 years of age for CML indication. Some children and adolescents taking VATIVIO may have slower than normal growth. The doctor will monitor the growth at regular visits.
Other medicines and VATIVIO
Before taking VATIVIO, tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription (such as paracetamol) and including herbal medicines (such as St. John’s wort). These include in particular:
- medicines used to treat infections such as ketoconazole, itraconazole, erythromycin, or clarithromycin,
- some medicines used to treat epilepsy such as carbamazepine, oxcarbazepine, phenobarbitone, phenytoin, fosphenytoin, or primidone,
- some medicines used to treat high cholesterol such as statins,
- some medicines used to treat mental disorders such as benzodiazepines or pimozide,
- some medicines used to treat high blood pressure or heart disorders such as calcium channel blockers or metoprolol.
Some medicines can interfere with the effect of VATIVIO when taken together. They may increase or decrease the effect of VATIVIO, either leading to increased side effects or making VATIVIO less effective. VATIVIO may do the same to some other medicines. Tell your doctor if you are using medicines that prevent the formation of blood clots.
Pregnancy, breast-feeding and fertility:
If you are pregnant or intend to become pregnant, or you are breast-feeding your baby, you should not use VATIVIO, as it may harm your baby. You should also not breast-feed your baby for 15 days after the last dose. Safety in human pregnancy and lactation has not been established. Females of child-bearing potential must use effective birth control while taking VATIVIO and for 15 days after ending treatment. If you are a man using VATIVIO, you must use a condom when having sexual intercourse. Birth defects have occurred in babies when pregnant women were treated with VATIVIO or whose father used VATIVIO.